Genzyme Therapeutics

4620 Kingsgate, Cascade Way, Oxford Business Park South, Oxford, Oxfordshire, OX4 2SU
Telephone: +44 (0)1865 405 200
Fax: +44 (0)1865 774 172
WWW: http://www.genzyme.co.uk
Medical Information Direct Line: +44 (0)1865 405 200
Medical Information e-mail: ukmedinfo@genzyme.com
Customer Care direct line: +44 (0)1865 405 200
Medical Information Fax: +44 (0)1865 774 172
Patient Information Leaflet last updated on the eMC: 05/01/2010
PIL MabCampath 30mg/ml concentrate for solution for infusion

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 05/01/2010 and displayed until Current
Reasons for adding or updating:
  • Change to date of revision
  • Change to warnings or special precautions for use
Updated on 28/10/2009 and displayed until 05/01/2010
Reasons for adding or updating:
  • Change to Further Information section
  • Change to date of revision
Updated on 02/06/2009 and displayed until 28/10/2009
Reasons for adding or updating:
  • Change to how the medicine works
  • Change to date of revision
  • Change to warnings or special precautions for use
  • Change of contra-indications
Updated on 26/01/2009 and displayed until 02/06/2009
Reasons for adding or updating:
  • Change to date of revision
  • Change to warnings or special precautions for use
Updated on 27/08/2008 and displayed until 26/01/2009
Reasons for adding or updating:
  • Change to date of revision
  • Improved Electronic Presentation
Updated on 07/03/2008 and displayed until 27/08/2008
Reasons for adding or updating:
  • Change to date of revision
  • Change to warnings or special precautions for use
Updated on 29/01/2008 and displayed until 07/03/2008
Reasons for adding or updating:
  • Change to date of revision
Updated on 07/01/2008 and displayed until 29/01/2008
Reasons for adding or updating:
  • Change to, or new, use for medicine
  • Change to date of revision
Updated on 03/01/2008 and displayed until 07/01/2008
Reasons for adding or updating:
  • Change to, or new, use for medicine
  • Change to date of revision
Updated on 03/08/2007 and displayed until 03/01/2008
Reasons for adding or updating:
  • Change to date of revision
  • Change to name of manufacturer
Updated on 24/09/2006 and displayed until 03/08/2007
Reasons for adding or updating:
  • Change to, or new, use for medicine
  • Change to warnings or special precautions for use
  • Change to information about pregnancy or lactation
  • Change to information about driving or using machinery
  • Change to side-effects
  • Change to storage instructions
  • Change to date of revision
Updated on 12/12/2005 and displayed until 24/09/2006
Reasons for adding or updating:
  • Company name change or merger
Updated on 10/05/2005 and displayed until 12/12/2005
Reasons for adding or updating:
  • Change of trade or generic name
  • Change to date of revision
Updated on 10/02/2004 and displayed until 10/05/2005
Reasons for adding or updating:
  • Update to PIL
Updated on 16/10/2002 and displayed until 10/02/2004
Reasons for adding or updating:
  • Update to PIL
Updated on 20/02/2002 and displayed until 16/10/2002
Reasons for adding or updating:
  • New PIL for eMC ie a PIL for an existing product but new to the eMC

Active Ingredients/Generics

 
   alemtuzumab


© 2010 Datapharm Communications Ltd

Go to www.medicines.org.uk